TigerOak Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$530K Sell
458
-20
-4% -$23.6K 0.14% 84
2026
Q2
$573K Hold
478
– – 0.16% 78
2026
Q1
$440K Hold
478
– – 0.14% 80
2025
Q4
$514K Hold
478
– – 0.16% 71
2025
Q3
$365K Sell
478
-158
-25% -$118K 0.11% 85
2025
Q2
$496K Sell
636
-40
-6% -$31.1K 0.17% 68
2025
Q1
$558K Hold
676
– – 0.22% 62
2024
Q4
$522K Buy
+676
New +$560K 0.19% 65

Other funds holding LLY

TigerOak Management's LLY Position: Q3 2026 in Review

TigerOak Management reduced its Eli Lilly (LLY) stake by 4.2% in Q3 2026, selling an estimated $23.6K and leaving 458 shares worth $530K. The position accounts for 0.14% of the portfolio, ranked #84.

TigerOak Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $573K in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • TigerOak Management held 458 shares of Eli Lilly worth $530K as of Q3 2026.
  • TigerOak Management sold 20 Eli Lilly shares in Q3 2026, an estimated $23.6K.
  • Eli Lilly made up 0.14% of TigerOak Management's portfolio in Q3 2026, its #84 holding.
  • TigerOak Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • TigerOak Management's Eli Lilly position peaked at $573K in Q2 2026.
  • 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on TigerOak Management's 13F filing for Q3 2026, filed 23 Oct 2026.